SEC Form 4 · accession 0001415889-15-001247
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Jemil Esber
Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 2:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F1,F2 | — | Apr 1, 2015 | A | 42,857 | A | — | — | Common Stock | 42,857 | 42,857 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F2The Reporting Person was granted a Restricted Stock Unit award on April 1, 2015 of 42,857 shares, which were fully vested on the date of grant.
- F3These restricted stock units were granted pursuant to the Issuer's 2014 Equity Incentive Plan.